Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes.

[1]  W. Haverkamp,et al.  A missense variant in desmoglein-2 predisposes to dilated cardiomyopathy. , 2008, Molecular genetics and metabolism.

[2]  I. V. Van Gelder,et al.  High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics. , 2007, American heart journal.

[3]  Y. Pinto,et al.  Severe myocardial fibrosis caused by a deletion of the 5' end of the lamin A/C gene. , 2007, Journal of the American College of Cardiology.

[4]  R. Hetzer,et al.  Corrected body surface potential mapping , 2007, Biomedizinische Technik. Biomedical engineering.

[5]  P. Charron,et al.  The genetic bases of cardiomyopathies , 2006 .

[6]  B. Soliven,et al.  Phospholamban R14 deletion results in late-onset, mild, hereditary dilated cardiomyopathy. , 2006, Journal of the American College of Cardiology.

[7]  G. Dorn,et al.  A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[8]  R. Felix,et al.  Myocardial viability assessment in patients with highly impaired left ventricular function: comparison of delayed enhancement, dobutamine stress MRI, end-diastolic wall thickness, and TI201-SPECT with functional recovery after revascularization , 2005, European Radiology.

[9]  Dudley J Pennell,et al.  The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[10]  E. Kranias,et al.  Calcium: Phospholamban: a crucial regulator of cardiac contractility , 2003, Nature Reviews Molecular Cell Biology.

[11]  G. Dorn,et al.  Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. , 2003, The Journal of clinical investigation.

[12]  Ulrike Mende,et al.  Dilated Cardiomyopathy and Heart Failure Caused by a Mutation in Phospholamban , 2003, Science.

[13]  Andrew N. Carr,et al.  Gender influences on sarcoplasmic reticulum Ca2+-handling in failing human myocardium. , 2001, Journal of molecular and cellular cardiology.

[14]  J. Seidman,et al.  Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. , 1999, The New England journal of medicine.

[15]  M. Böhm,et al.  Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy , 2008, Basic Research in Cardiology.

[16]  O. Simonetti,et al.  An improved MR imaging technique for the visualization of myocardial infarction. , 2001, Radiology.

[17]  L. Mestroni,et al.  Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. , 1999, European heart journal.

[18]  H. Katus,et al.  Frequency and phenotypes of familial dilated cardiomyopathy. , 1998, Journal of the American College of Cardiology.